Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add‐on mirabegron therapy to solifenacin (BESIDE)

por Drake, Marcus J., MacDiarmid, Scott, Chapple, Christopher R., Esen, Adil, Athanasiou, Stavros, Cambronero Santos, Javier, Mitcheson, David, Herschorn, Sender, Siddiqui, Emad, Huang, Moses, Stoelzel, Matthias
Publicado 2017